Dimensional Fund Advisors’s INmune Bio INMB Stock Holding History

Dimensional Fund Advisors’s Portfolio INMB Stock Details INMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12K	Hold	10,581	–	–	﹤0.01%	3213
2025 Q4	$16.5K	Hold	10,581	–	–	﹤0.01%	3239
2025 Q3	$21.9K	Sell	10,581 -14,558	-58%	-$33.3K	﹤0.01%	3266
2025 Q2	$58.1K	Hold	25,139	–	–	﹤0.01%	3227
2025 Q1	$196K	Hold	25,139	–	–	﹤0.01%	3132
2024 Q4	$117K	Buy	25,139 +10,491	+72%	+$54.7K	﹤0.01%	3227
2024 Q3	$79K	Buy	+14,648	New	+$104K	﹤0.01%	3256
2022 Q1	–	Sell	-11,052	Closed	-$113K	–	3532
2021 Q4	$113K	Hold	11,052	–	–	﹤0.01%	3422
2021 Q3	$215K	Hold	11,052	–	–	﹤0.01%	3337
2021 Q2	$194K	Hold	11,052	–	–	﹤0.01%	3341
2021 Q1	$131K	Hold	11,052	–	–	﹤0.01%	3327
2020 Q4	$190K	Sell	11,052 -4,976	-31%	-$46.9K	﹤0.01%	3229
2020 Q3	$165K	Buy	+16,028	New	+$163K	﹤0.01%	3221

Other funds holding INMB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dimensional Fund Advisors's INMB Position: Q1 2026 in Review

Dimensional Fund Advisors held its INmune Bio (INMB) position steady in Q1 2026 at 10,581 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #3213.

Dimensional Fund Advisors first reported a position in INMB in Q3 2020 and has held it in 13 quarters since. The position peaked at $215K in Q3 2021. 82 funds tracked by Wall St. Rank hold INMB as of Q1 2026.

Dimensional Fund Advisors held 10,581 shares of INmune Bio worth $12K as of Q1 2026.
Dimensional Fund Advisors left its INmune Bio share count unchanged in Q1 2026.
INmune Bio made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #3213 holding.
Dimensional Fund Advisors first reported a position in INmune Bio in Q3 2020 and has held it in 13 quarters since.
Dimensional Fund Advisors's INmune Bio position peaked at $215K in Q3 2021.
82 funds tracked by Wall St. Rank held INmune Bio as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.